LC
TMO icon

Legacy CG’s Thermo Fisher Scientific TMO Stock Holding History

Legacy CG’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,593
Closed -$2.07M – 54
2023
Q1 		$2.07M Buy
3,593
+8
+0.2% +$4.51K 1.05% 35
2022
Q4 		$1.97M Buy
3,585
+197
+6% +$104K 1.16% 35
2022
Q3 		$1.72M Buy
+3,388
New +$1.9M 1.13% 37

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Legacy CG's TMO Position: Q2 2023 in Review

Legacy CG sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 3,593 shares — an estimated $2.07M sold.

Legacy CG first reported a position in TMO in Q3 2022 and held it in 3 quarters. The position peaked at $2.07M in Q1 2023. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Legacy CG reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Legacy CG sold 3,593 Thermo Fisher Scientific shares in Q2 2023, an estimated $2.07M.
  • Legacy CG first reported a position in Thermo Fisher Scientific in Q3 2022 and held it in 3 quarters.
  • Legacy CG's Thermo Fisher Scientific position peaked at $2.07M in Q1 2023.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Legacy CG's 13F filing for Q2 2023, filed 2 Aug 2023.